Cargando…
The effects of crizotinib in a transgenic Drosophila model expressing the human TPM4-ALK fusion gene or TPM4
Anaplastic lymphoma kinase (ALK) fusion events lead to constitutive activation of the ALK kinase domain, thereby functioning as oncogenic drivers. These fusion proteins have been identified in numerous cancers. Crizotinib, a small molecule inhibitor of c-Met and ALK, is a Food and Drug Administratio...
Autores principales: | Kim, Yoo Jin, Cho, A-Ri, Sul, Hee Jung, Kim, Bohyun, Kim, A-Young, Kim, Hyeong Su, Seo, Jong Bok, Koh, Youngho, Zang, Dae Young |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679403/ https://www.ncbi.nlm.nih.gov/pubmed/31278140 http://dx.doi.org/10.1242/bio.044362 |
Ejemplares similares
-
Characteristics of Renal Cell Carcinoma Harboring TPM3-ALK Fusion
por: Woo, Chang Gok, et al.
Publicado: (2020) -
TPM3 and TPM4 gene products segregate to the postsynaptic region of central nervous system synapses
por: Guven, Kim, et al.
Publicado: (2011) -
Implementing TPM
por: Ginder, Andrew, et al.
Publicado: (2020) -
Structural and Functional Peculiarities of Cytoplasmic Tropomyosin Isoforms, the Products of TPM1 and TPM4 Genes
por: Marchenko, Marina, et al.
Publicado: (2021) -
ORMDL3 expression in ASM regulates hypertrophy, hyperplasia via TPM1 and TPM4, and contractility
por: Pham, Alexa K., et al.
Publicado: (2021)